GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Price-to-Owner-Earnings

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Price-to-Owner-Earnings : (As of May. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Price-to-Owner-Earnings?

As of today (2024-05-14), Oxford Cannabinoid Technologies Holdings's share price is €0.001. Oxford Cannabinoid Technologies Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's Price-to-Owner-Earnings or its related term are showing as below:


FRA:0CB's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 35.165
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-14), Oxford Cannabinoid Technologies Holdings's share price is €0.001. Oxford Cannabinoid Technologies Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 was €-0.01. Therefore, Oxford Cannabinoid Technologies Holdings's PE Ratio for today is At Loss.

As of today (2024-05-14), Oxford Cannabinoid Technologies Holdings's share price is €0.001. Oxford Cannabinoid Technologies Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.01. Therefore, Oxford Cannabinoid Technologies Holdings's PE Ratio without NRI for today is At Loss.


Oxford Cannabinoid Technologies Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Price-to-Owner-Earnings Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Price-to-Owner-Earnings
- - - - -

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Price-to-Owner-Earnings

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Price-to-Owner-Earnings falls into.



Oxford Cannabinoid Technologies Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Oxford Cannabinoid Technologies Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.001/-0.01
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Cannabinoid Technologies Holdings  (FRA:0CB) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Oxford Cannabinoid Technologies Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines